Edward P. Feener, CHIEF SCIENTIFIC OFFICER at KalVista Pharmaceuticals, Inc. (KALV), sold 56,342 shares at $15.01 ($846K) on 2024-02-14, disclosed to the SEC on 2024-02-16.
Open-market sale of $846k KALV by CHIEF SCIENTIFIC OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.01 | 28,171 | $423K | 50.0% |
| 2 | $15.01 | 28,171 | $423K | 50.0% |
| Total | $15.01 avg | 56,342 | $846K | 100% |
| Filing → |
| KALV | SELL | 2024-01-12 | $591K | — | Filing → |
| KALV | SELL | 2024-01-10 | $449K | — | Filing → |
| KALV | SELL | 2023-11-21 | $41K | — | Filing → |